Jan-jaap Verhoef

Q: What Schools Are Affiliated With Jan-jaap Verhoef

Jan-jaap Verhoef is affiliated with the following schools: Dalhousie University, Utrecht University

Jan-jaap Verhoef's AcademicInfluence.com Rankings

Jan-jaap Verhoef

Biology

#5132

World Rank

#7541

Historical Rank

Microbiology

#191

World Rank

#223

Historical Rank

Molecular Biology

#443

World Rank

#452

Historical Rank

Genetics

#447

World Rank

#516

Historical Rank

biology Degrees

Download Badge

Biology

Jan-jaap Verhoef's Degrees

PhD Microbiology University of Amsterdam
Masters Biomedical Sciences University of Amsterdam
Bachelors Biomedical Sciences University of Amsterdam

Why Is Jan-jaap Verhoef Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jan-jaap Verhoef's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates (2005) (1152)
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock (1990) (520)
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). (2001) (486)
Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. (1995) (405)
Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. (1990) (380)
Epidemiology and Susceptibility of 3,051Staphylococcus aureus Isolates from 25 University Hospitals Participating in the European SENTRY Study (2001) (337)
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. (2000) (325)
Lipoprotein metabolism in patients with severe sepsis (2003) (308)
Molecular typing of methicillin-resistantStaphylococcus aureus on the basis of protein A gene polymorphism (2005) (305)
Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Monocytes Involves the Raf-1/MEK1-MEK2/ERK1-ERK2 Pathway (1999) (280)
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). (1999) (277)
Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. (2003) (277)
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. (1998) (269)
Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping. (2001) (266)
From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. (1990) (261)
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. (1988) (253)
Prevention of colonization and infection in critically ill patients: a prospective randomized study. (1988) (243)
The magnetic immuno polymerase chain reaction assay for direct detection of salmonellae in fecal samples (1992) (237)
Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages. (2001) (233)
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. (2004) (232)
Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria. (1977) (229)
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. (1987) (222)
The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. (1999) (220)
Plasminogen Activator Inhibitor 1: A New Prognostic Marker in Septic Shock (1989) (213)
Effect of protein A on staphylococcal opsonization (1977) (208)
Interactions of surfactant protein A with influenza A viruses: binding and neutralization. (1995) (205)
Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages. (1995) (203)
Discrimination of epidemic and nonepidemic methicillin-resistant Staphylococcus aureus strains on the basis of protein A gene polymorphism (1994) (199)
Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. (1981) (199)
A Dutch Approach to Methicillin-Resistant Staphylococcus aureus (1999) (197)
Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans (1993) (194)
Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. (2000) (190)
The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. (1998) (190)
Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. (1994) (186)
Quantitation of surface CD14 on human monocytes and neutrophils (1997) (173)
mecA Gene Is Widely Disseminated in Staphylococcus aureus Population (2002) (173)
Evidence for in-vivo transfer of mecA DNA between strains of Staphylococcus aureus (2001) (172)
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. (1978) (166)
Diversity and Evolution of the Class A Chromosomal Beta-Lactamase Gene in Klebsiella pneumoniae (2004) (164)
Presence of Integron-Associated Resistance in the Community Is Widespread and Contributes to Multidrug Resistance in the Hospital (2002) (163)
Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. (1999) (162)
A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. (1993) (161)
The millennium bugs--the need for and development of new antibacterials. (2000) (160)
Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. (1977) (160)
Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. (1991) (156)
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. (1998) (154)
Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates (2003) (153)
Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting. (2002) (151)
Frequency of Isolation of Pathogens from Bloodstream, Nosocomial Pneumonia, Skin and Soft Tissue, and Urinary Tract Infections Occurring in European Patients (2001) (148)
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. (1990) (146)
Clinical Efficacy and Morbidity Associated with Continuous Cyclic Compared with Continuous Ambulatory Peritoneal Dialysis (1994) (135)
Detection of Listeria monocytogenes in cheese with the magnetic immuno-polymerase chain reaction assay (1993) (135)
Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A. (1992) (134)
Role of Healthcare Workers in Outbreaks of Methicillin-Resistant Staphylococcus aureus: A 10-Year Evaluation From a Dutch University Hospital (2003) (134)
Costs Associated with a Strict Policy to Eradicate Methicillin-Resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-Year Survey (2002) (133)
Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene (1991) (132)
Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-α, interleukin-1β and interleukin-6 (1993) (132)
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. (2004) (129)
Characterization of grlA, grlB, gyrA, and gyrB Mutations in 116 Unrelated Isolates of Staphylococcus aureus and Effects of Mutations on Ciprofloxacin MIC (1998) (128)
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. (1985) (128)
The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. (1998) (126)
Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. (2002) (125)
Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV‐1‐associated dementia (2000) (125)
Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. (1998) (124)
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. (2003) (122)
Rapid detection of salmonellae in poultry with the magnetic immuno-polymerase chain reaction assay (1993) (121)
Frequency of Isolation and Antimicrobial Resistance of Gram-Negative and Gram-Positive Bacteria from Patients in Intensive Care Units of 25 European University Hospitals Participating in the European Arm of the SENTRY Antimicrobial Surveillance Program 1997–1998 (2001) (120)
Cytotoxic Effects of Commercial Continuous Ambulatory Peritoneal Dialysis (CAPD) Fluids and of Bacterial Exoproducts on Human Mesothelial Cells in Vitro (1989) (120)
Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. (1985) (118)
Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria (1997) (116)
Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline (2005) (116)
Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 Automated Instruments for Detection of Extended-Spectrum Beta-Lactamases in Multiresistant Escherichia coli and Klebsiella spp (2002) (114)
The sepsis syndrome in a Dutch university hospital. Clinical observations. (1993) (113)
Genomic Diversity within the Enterobacter cloacae Complex (2008) (113)
Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. (1978) (113)
Functional defects in phagocytic cells from patients with iron overload. (1984) (112)
Airborne gram-negative bacteria and endotoxin in sick building syndrome. A study in Dutch governmental office buildings. (1994) (112)
Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. (1999) (111)
Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus. (1998) (111)
Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group. (1999) (107)
Many Class I Integrons Comprise Distinct Stable Structures Occurring in Different Species ofEnterobacteriaceae Isolated from Widespread Geographic Regions in Europe (1999) (105)
Rapid identification of bacteria by PCR-single-strand conformation polymorphism (1994) (104)
Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. (1993) (104)
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. (1997) (102)
Antibiotic rotation and development of gram-negative antibiotic resistance. (2005) (100)
In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial Isolates (2000) (100)
In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. (2001) (100)
Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplement (1987) (99)
Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. (2001) (99)
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates. (2001) (98)
Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. (1999) (95)
Site-Specific Manifestations of Invasive Group A Streptococcal Disease: Type Distribution and Corresponding Patterns of Virulence Determinants (2003) (95)
Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells (2008) (94)
Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. (1982) (93)
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. (1977) (92)
Typing of methicillin-resistant Staphylococcus aureus isolates from Düsseldorf by six genotypic methods. (1998) (87)
Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997 (2000) (85)
Development of a rapid identification method for Klebsiella pneumoniae phylogenetic groups and analysis of 420 clinical isolates. (2004) (85)
Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils. (1991) (84)
Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR. (1997) (84)
Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. (2000) (84)
Enterobacter cloacae Outbreak and Emergence of Quinolone Resistance Gene in Dutch Hospital (2006) (83)
Dual effects of soluble CD14 on LPS priming of neutrophils (1997) (82)
Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureu (1999) (80)
Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis (1996) (80)
Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis. (1983) (80)
Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections. (1981) (80)
Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus. (1983) (80)
Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene (1995) (80)
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages (1981) (80)
Characterization and description of "Campylobacter upsaliensis" isolated from human feces (1990) (79)
Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV (1977) (79)
Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein. (1993) (78)
In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. (1993) (78)
Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes (1976) (77)
Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. (1993) (77)
Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization (1979) (76)
Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. (2005) (76)
Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. (2006) (76)
Synthetic 6B Di-, Tri-, and Tetrasaccharide-Protein Conjugates Contain Pneumococcal Type 6A and 6B Common and 6B- Specific Epitopes That Elicit Protective Antibodies in Mice (2001) (75)
A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia. (1991) (75)
Enhanced expression of fractalkine in HIV-1 associated dementia (2001) (74)
Pneumococcal virulence factors and host immune responses to them (1995) (73)
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells (1997) (73)
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. (2000) (73)
Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. (1992) (73)
Initiation of the respiratory burst of human neutrophils by influenza virus (1981) (72)
Colonization and infection in surgical intensive care patients —a prospective study (2004) (72)
Prevalence of Aminoglycoside Resistance in 20 European University Hospitals Participating in the European SENTRY Antimicrobial Surveillance Programme (1999) (72)
Comparative Evaluation of the BD Phoenix and VITEK 2 Automated Instruments for Identification of Isolates of the Burkholderia cepacia Complex (2002) (71)
Serum Amyloid P Component Bound to Gram-Negative Bacteria Prevents Lipopolysaccharide-Mediated Classical Pathway Complement Activation (2000) (69)
Relationship of bacterial growth phase to killing of Listeria monocytogenes by oxidative agents generated by neutrophils and enzyme systems (1987) (69)
Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion. (1989) (68)
Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains (1997) (67)
Modulation of Neutrophil Chemokine Receptors by Staphylococcus aureus Supernate (2000) (67)
Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes. (1984) (67)
In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci. (1978) (67)
Evaluation of the Magnetic Immuno PCR assay for rapid detection ofSalmonella (1991) (67)
Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies. (1980) (65)
Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors (1994) (65)
Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis (2005) (64)
Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes (1997) (64)
Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates. (1998) (63)
Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis. (1998) (63)
The amino-terminus of the amyloid-β protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages (1999) (63)
Molecular Surveillance of European Quinolone-Resistant Clinical Isolates of Pseudomonas aeruginosa andAcinetobacter spp. Using Automated Ribotyping (2000) (63)
Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry (1995) (62)
Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9 (2011) (61)
The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization. (1979) (61)
The role of high density lipoprotein in sepsis. (2001) (61)
Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. (2006) (61)
Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. (2002) (60)
Modulation of adherence of coagulase-negative staphylococci to teflon catheters in vitro (1986) (60)
The Antimicrobial agents annual (1986) (60)
Acquisition and Cross-Transmission of Staphylococcus aureus in European Intensive Care Units (2009) (60)
A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. (1998) (59)
Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6. (1993) (59)
Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group. (1997) (59)
Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice. (1995) (58)
Yersiniabactin Reduces the Respiratory Oxidative Stress Response of Innate Immune Cells (2009) (58)
Development of Resistance to Ciprofloxacin, Rifampin, and Mupirocin in Methicillin-Susceptible and -ResistantStaphylococcus aureus Isolates (2000) (58)
Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis. (1995) (58)
Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18. (1999) (57)
Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes (1983) (57)
Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Pathogens Associated with Skin and Soft Tissue Infections During 1997 from an International Surveillance Programme (1999) (57)
Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program. (2001) (57)
Novel Gene Cassettes and Integrons (2001) (56)
Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. (1992) (56)
Novel Mobile Variants of Staphylococcal Cassette Chromosome mec in Staphylococcus aureus (2006) (56)
Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family. (1983) (56)
Opsonic defense to Staphylococcus epidermidis in the premature neonate. (1985) (55)
Escherichia coli antibodies in opsonisation and protection against infection. (1981) (55)
Comparison of immunomagnetic beads coated with protein A, protein G, or goat anti-mouse immunoglobulins. Applications in enzyme immunoassays and immunomagnetic separations. (1993) (55)
Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. (2000) (55)
Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain. (2009) (54)
Antimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosis (2007) (54)
What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals? (2002) (54)
Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cell monolayers. (1990) (53)
The role of cytokines in gram-positive bacterial shock. (1995) (53)
Structural and functional changes of surfactant protein A induced by ozone. (1991) (53)
Surveillance of nosocomial infections in geriatric patients. (1997) (52)
Use of Highly Encapsulated Streptococcus pneumoniae Strains in a Flow-Cytometric Assay for Assessment of the Phagocytic Capacity of Serotype-Specific Antibodies (1998) (52)
Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG (1994) (52)
Identification of coagulase-negative staphylococci other than Staphylococcus epidermidis by automated ribotyping. (2005) (51)
Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia. (1982) (51)
Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines. (2000) (51)
Genesis of BRO β‐lactamase‐producing Moraxella catarrhalis: evidence for transformation‐mediated horizontal transfer (2000) (50)
Prevention of infections in the neutropenic patient. (1993) (50)
Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B (1991) (50)
Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. (1992) (50)
Bacterial resistance: A sensitive issue (2006) (50)
Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism. (2004) (50)
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. (1999) (50)
Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis. (2009) (50)
Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay (1994) (50)
Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates. (2001) (49)
Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation (1994) (49)
Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar. (1996) (49)
Neutrophil function, serum opsonic activity, and delayed hypersensitivity in surgical patients. (1982) (49)
Comparative In Vitro Activities of Ciprofloxacin, Clinafloxacin, Gatifloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin againstKlebsiella pneumoniae, Klebsiella oxytoca,Enterobacter cloacae, and Enterobacter aerogenes Clinical Isolates with Alterations in GyrA and ParC Proteins (1999) (49)
Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea (1989) (49)
Lipopolysaccharide (LPS)-Binding Synthetic Peptides Derived from Serum Amyloid P Component Neutralize LPS (1999) (48)
Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. (1994) (48)
An outbreak of Serratia marcescens traced to a contaminated bronchoscope. (1993) (48)
Activation of Human Macrophages by Amyloid-β Is Attenuated by Astrocytes1 (2001) (48)
Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment. (2000) (47)
In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus (2001) (47)
Automated Ribotyping of Vancomycin-Resistant Enterococcus faecium Isolates (2002) (47)
Antimicrobial resistance among community-acquired pneumonia isolates in Europe: First results from the SENTRY antimicrobial surveillance program 1997 (1999) (47)
Increased Prevalence of Class I Integrons inEscherichia coli, Klebsiella Species, andEnterobacter Species Isolates over a 7-Year Period in a German University Hospital (2001) (46)
Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA). (2001) (46)
Pathogenesis of Gram-negative Bacterial Infections (1988) (46)
Influence of temperature on opsonization and phagocytosis of staphylococci (1977) (46)
Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens. (2001) (46)
Long-term carriage, and transmission of methicillin-resistant Staphylococcus aureus after discharge from hospital. (1992) (46)
Bacterial and viral removal efficiency, heat and moisture exchange properties of four filtration devices. (1995) (46)
Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex (1999) (46)
Moraxella (Branhamella)catarrhalis BRO β-Lactamase: a Lipoprotein of Gram-Positive Origin? (1999) (46)
Exposure of surfactant protein A to ozone in vitro and in vivo impairs its interactions with alveolar cells. (1992) (45)
Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS. (2000) (45)
Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes. (1984) (45)
Microbiologic risk of invasive hemodynamic monitoring in patients undergoing open‐heart operations (1985) (45)
Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe). (1999) (44)
In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in Europe (2007) (44)
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates (1991) (44)
Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates (1991) (44)
Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992–1996 (2004) (44)
Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone (1991) (44)
Distinguishing Species of the Burkholderia cepacia Complex and Burkholderia gladioli by Automated Ribotyping (2000) (44)
Complement-mediated phagocytosis of Pseudomonas aeruginosa. (1978) (43)
Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst. (1997) (43)
The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial. (2004) (43)
Human polymorphonuclear leucocyte receptors for staphylococcal opsonins. (1977) (42)
Antimicrobial Resistance in European Isolates of Pseudomonas aeruginosa (2000) (42)
Quantitation of the Third Component of Human Complement Attached to the Surface of Opsonized Bacteria: Opsonin-Deficient Sera and Phagocytosis-Resistant Strains (1979) (42)
Chemotaxigenesis by cell surface components of Staphylococcus aureus (1979) (42)
Bacterial iron enhances oxygen radical-mediated killing of Staphylococcus aureus by phagocytes (1990) (42)
Pharmacokinetics of cefepime in patients with the sepsis syndrome. (1993) (42)
Mechanism of protection of alveolar type II cells against paraquat-induced cytotoxicity by deferoxamine. (1990) (42)
Epidemiology of Quinolone Resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe (2000) (42)
Partial removal of sialic acid enhances phagocytosis and the generation of superoxide and chemiluminescence by polymorphonuclear leukocytes. (1982) (42)
Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis? (1994) (42)
Methicillin-Resistant Staphylococcus Aureus Carriage Among Patients After Hospital Discharge (2005) (41)
In Vitro Activity of Daptomycin against Gram-Positive European Clinical Isolates with Defined Resistance Determinants (2004) (41)
Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species. (1999) (41)
Priorities for antibiotic resistance surveillance in Europe. (2006) (40)
Antibodies and complement enhance binding and uptake of HIV‐1 by human monocytes (1992) (40)
COMPARISON OF ONCE DAILY CEFTRIAXONE WITH GENTAMICIN PLUS CEFUROXIME FOR TREATMENT OF SERIOUS BACTERIAL INFECTIONS (1988) (40)
Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci. (1982) (40)
Induction of cyclooxygenase‐2 expression during HIV‐1‐infected monocyte‐derived macrophage and human brain microvascular endothelial cell interactions (2000) (40)
Effect of iron on neonatal gut flora during the first three months of life (1985) (39)
Clindamycin enhances opsonization of Staphylococcus aureus (1983) (39)
International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections. (1993) (39)
Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus. (1981) (39)
Evolution in Quantum Leaps: Multiple Combinatorial Transfers of HPI and Other Genetic Modules in Enterobacteriaceae (2010) (38)
Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface (1990) (38)
Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV‐1 replication (1997) (38)
Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. (1993) (38)
Virulence factors of genotyped bovine mastitis Staphylococcus aureus isolates in The Netherlands. (2010) (37)
Prevention of bacteremia caused by α-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin (1989) (37)
Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide. (1993) (36)
Relative risk of physicians and nurses to transmit pathogens in a medical intensive care unit. (2003) (36)
Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis. (1979) (36)
Phage-typing of coagulase-negative staphylococci. (1972) (36)
Impairment of phagocytic functions of alveolar macrophages by hydrogen peroxide. (1990) (35)
Cyclosporiasis Outbreak, Indonesia (2005) (35)
Extensive Hospital-Wide Spread of a Multidrug-Resistant Enterobacter cloacae Clone, with Late Detection Due to a Variable Antibiogram and Frequent Patient Transfer (2006) (35)
Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins. (1984) (34)
Complement resistance in Branhamella (Moraxella) catarrhalis (1993) (34)
Inhibition of bacterial multiplication by the iron chelator deferoxamine: Potentiating effect of ascorbic acid (1983) (34)
Daptomycin in vitro susceptibility in European Gram-positive clinical isolates. (2004) (34)
Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells. (1992) (34)
A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections. (1993) (34)
Cardiopulmonary bypass and host defense functions in human beings: I. Serum levels and role of immunoglobulins and complement in phagocytosis. (1985) (33)
Quantifying the relationship between Staphylococcus aureus bacteremia and S. aureus bacteriuria: a retrospective analysis in a tertiary care hospital. (2007) (33)
Production of BRO β-Lactamases and Resistance to Complement in European Moraxella catarrhalis Isolates (2002) (33)
Cellular aspects of HIV‐1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV‐1 encephalitis (1997) (33)
Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants (1993) (33)
Coagulase-negative staphylococci as nosocomial pathogens in neonates. The role of host defense, artificial devices, and bacterial hydrophobicity. (1986) (32)
Species differences in impairment and recovery of alveolar macrophage functions following single and repeated ozone exposures. (1991) (32)
Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains. (1998) (32)
Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes (1996) (32)
Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America (2011) (32)
Effects of lysosomotropic amines on human polymorphonuclear leucocyte function. (1984) (32)
Association of Alterations in ParC and GyrA Proteins with Resistance of Clinical Isolates of Enterococcus faecium to Nine Different Fluoroquinolones (1999) (32)
Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes (1985) (31)
Novel Multiple-Locus Variable-Number Tandem-Repeat Analysis Method for Rapid Molecular Typing of Human Staphylococcus aureus (2008) (31)
Characters of phages from coagulase-negative staphylococci. (1971) (31)
Determining risk factors for methicillin-resistant Staphylococcus aureus carriage after discharge from hospital. (1999) (31)
Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation (1988) (31)
Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody. (1990) (31)
Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group. (1999) (30)
Issues in the adjunct therapy of severe sepsis. (1996) (30)
Enhancement of human natural killer cell activity by subcellular components of Toxoplasma gondii. (1984) (30)
Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli. (2000) (29)
Monoclonal antibodies that react with live Listeria spp (1993) (29)
Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2. (1979) (29)
Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates. (2001) (29)
Integrons in Escherichia coli from food-producing animals in The Netherlands. (2005) (29)
A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis. (1990) (29)
Susceptibility of 302 Methicillin-Resistant Staphylococcus aureus Isolates from 20 European University Hospitals to Vancomycin and Alternative Antistaphylococcal Compounds (1999) (29)
Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14. (1993) (28)
A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections. (1995) (28)
Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines (1995) (28)
Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker (2019) (28)
A view to a kill: cytotoxic mechanisms of human polymorphonuclear leukocytes compared with monocytes and natural killer cells. (1990) (28)
Host defence to bacterial infection in the neonate. (1988) (28)
Pharmacokinetics of cefepime in patients with respiratory tract infections (1990) (28)
Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method (1995) (27)
Rothia dentocariosa endocarditis complicated by an abdominal aneurysm. (1994) (27)
Diverging pathways for lipopolysaccharide and CD14 in human monocytes. (2000) (27)
Comparative Activity of 27 Antimicrobial Compounds Against 698 Streptococcus pneumoniae Isolates Originating from 20 European University Hospitals (1999) (27)
An evaluation of the role of surface hydrophobicity and extracellular slime in the pathogenesis of foreign-body-related infections due to coagulase-negative staphylococci. (1989) (27)
Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains (1993) (27)
Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients (1992) (27)
Acquisition and Duration of Vancomycin-Resistant Enterococcal Carriage in Relation to Strain Type (2003) (26)
The role of tumour necrosis factor in the kinetics of lipopolysaccharide‐mediated neutrophil priming in whole blood (2005) (26)
Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines (1995) (26)
Interactions of phagocytic and bacterial cells in patients with bacteremia caused by gram-negative rods. (1980) (26)
Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus (1995) (26)
Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus (1981) (25)
Bacterial cell wall components decrease the number of guinea-pig lung beta-adrenoceptors. (1983) (25)
Effect of human polymorphonuclear and mononuclear leukocytes on chromosomal and plasmid DNA of Escherichia coli. Role of acid DNase. (1984) (25)
Carumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough Escherichia coli J5 (1987) (25)
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. (2002) (25)
Inhibition of human natural killer activity by lysosomotropic agents. (1983) (24)
Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines. (1994) (24)
Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children. (1994) (24)
Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations. (1989) (24)
In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status. (2002) (24)
Failure To Control an Outbreak of qnrA1-Positive Multidrug-Resistant Enterobacter cloacae Infection despite Adequate Implementation of Recommended Infection Control Measures (2007) (24)
Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting (1985) (24)
Macrophages, cytokines, and HIV. (1997) (24)
Determination of the Relationship between Group A Streptococcal Genome Content, M Type, and Toxic Shock Syndrome by a Mixed Genome Microarray (2007) (23)
Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles. (1991) (23)
Influence of polymorphonuclear granulocytes on the zona-free hamster oocyte assay. (1991) (23)
[Nasopharyngeal isolates of S. pneumoniae from healthy carriers and children with pneumonia: colonization rates and antimicrobial susceptibility]. (2002) (23)
Comparison of a Classical Phagocytosis Assay and a Flow Cytometry Assay for Assessment of the Phagocytic Capacity of Sera from Adults Vaccinated with a Pneumococcal Conjugate Vaccine (2001) (23)
A decade of experience with selective decontamination of the digestive tract as prophylaxis for infections in patients in the intensive care unit: what have we learned? (1993) (22)
Antimicrobial susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in children with pneumonia and in children attending day-care centres in Fortaleza, Brazil. (2002) (22)
Phagocytosis of staphylococci by human polymorphonuclear leukocytes is enhanced in the presence of endothelial cells (1985) (22)
Antibiotic resistance: the pandemic. (2003) (22)
Control of epidemic methicillin-resistantStaphylococcus aureus in a Dutch University Hospital (2005) (22)
Host determinants in staphylococcal disease. (1981) (22)
The stability of grlA, grlB, gyrA, gyrB and norA mutations and MIC values of five fluoroquinolones in three different clonal populations of methicillin-resistant Staphylococcus aureus. (1999) (21)
Genetic Diversity Among Strains of Moraxella catarrhalis Cultured from the Nasopharynx of Young and Healthy Brazilian, Angolan and Dutch Children (2000) (21)
Role of mesothelial cells in peritoneal antibacterial defence. (1991) (21)
Moraxella catarrhalis in acute laryngitis: infection or colonization? (1996) (21)
Activation of polymorphonuclear leukocytes by spermatozoa. (1985) (21)
Striking differences in the nasopharyngeal flora of healthy Angolan, Brazilian and Dutch children less than 5 years old. (1999) (21)
Lipid peroxidation of human granulocytes (PMN) and monocytes by iron complexes (1989) (21)
Enhancement of HIV‐1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte‐dependent but tumour necrosis factor‐independent (1994) (20)
Lysogeny in coagulase-negative staphylococci. (1971) (20)
Deficiencies in Opsonic Defense to Pneumococci in the Human Newborn Despite Adequate Levels of Complement and Specific IgG Antibodies (1990) (20)
Injury to endothelial cells by phagocytosing polymorphonuclear leukocytes and modulatory role of lipoxygenase products (1987) (20)
Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin (1983) (20)
Pharmacokinetics of the new penicillins. Amoxycillin and flucloxacillin in patients with terminal renal failure undergoing haemodialysis. (1973) (20)
Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis. (1994) (20)
New criteria for antimicrobial therapy, maintenance of digestive tract colonization resistance : proceedings of a symposium, Utrecht, January 1979 (1979) (20)
EndemicAcinetobacter anitratus in a surgical intensive care unit: Mechanical ventilators as reservoir (1988) (20)
Chemiluminescence of human polymorphonuclear leucocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermidis. (1993) (20)
Prevention of infection in the neutropenic patient. (1989) (20)
Phagocytosis of herpes simplex virus by human granulocytes and monocytes (2005) (20)
Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear granulocytes (2005) (19)
Effect of influenza viras on phagocytic cells (1982) (19)
Activation of human macrophages by amyloid-beta is attenuated by astrocytes. (2001) (19)
Surveillance uncovers the smoking gun for resistance emergence. (2006) (19)
Propensity of Fluoroquinolones with Different Moieties at Position 8 to Cause Resistance Development in Clinical Isolates of Streptococcus pneumoniae (2001) (19)
Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection. (1993) (19)
Toxins A and B of Clostridium difficile. (1994) (19)
Staphylococcus epidermidis endocarditis and Staphylococcus epidermidis infection in an intensive care unit. (1983) (19)
Endotoxic effects of peptidoglycan. (1985) (19)
Staphylococcal Culture Supernates Stimulate Human Phagocytes (1997) (19)
Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria (1983) (18)
Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime. (1989) (18)
Dynamics in Prophage Content of Invasive and Noninvasive M1 and M28 Streptococcus pyogenes Isolates in The Netherlands from 1959 to 1996 (2007) (18)
Once-daily aminoglycoside administration: New strategies for an old drug (1989) (18)
Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo. (1991) (18)
Genogeography and Immune Epitope Characteristics of Hepatitis B Virus Genotype C Reveals Two Distinct Types: Asian and Papua-Pacific (2015) (17)
Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada (2008) (17)
Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies. (1989) (17)
Monoclonal antibodies that detect live salmonellae (1992) (17)
In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci. (2002) (17)
Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections (1990) (17)
Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus. (1987) (17)
Polynuclear iron complexes impair the function of polymorphonuclear granulocytes (1988) (17)
Clinical evaluation of a NASBA-based assay for detection of Candida spp. in blood and blood cultures. (2002) (16)
Aggregation of human polymorphonuclear leucocytes during phagocytosis of bacteria. (1984) (16)
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae colonizing children with community-acquired pneumonia and children attending day-care centres in Fortaleza, Brazil. (2000) (16)
The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies. (1991) (16)
Defective Complement-Mediated Opsonization and Lysis of Bacteria in Commercial Peritoneal Dialysis Solutions (1986) (16)
The role of glycocalyx in surface phagocytosis of Bacteroides spp., in the presence and absence of clindamycin. (1989) (16)
Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes. (1990) (16)
The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo. (1991) (16)
Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A. (1993) (16)
Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics. (2000) (16)
Uncoupling of Oxidative and Non‐Oxidative Mechanisms in Human Granulocyte‐Mediated Cytotoxicity: Use of Cytoplasts and Cells From Chronic Granulomatous Disease Patient (1990) (16)
Effect of iron on neonatal gut flora during the first week of life (1985) (16)
Modulation of lipopolysaccharide binding to human granulocytes. (1994) (15)
Differences in the effect of arachidonic acid on polymorphonuclear and mononuclear leukocyte function. (1984) (15)
LIPOPOLYSACCHARIDE INDUCES HYPERADHESION OF ENDOTHELIAL CELLS FOR NEUTROPHILS LEADING TO DAMAGE (1994) (15)
Limiting factors in bacterial phagocytosis by human polymorphonuclear leukocytes. (2009) (15)
Colonization with Multiple Staphylococcus aureus Strains among Patients in European Intensive Care Units (2009) (15)
Modulation of phagocytic cell function (1986) (15)
Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci. (1996) (15)
Comparison of typing methods for Clostridium difficile isolates (1993) (15)
Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa. (2002) (15)
In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function. (1994) (15)
Role for oxygen radicals in self‐sustained HIV‐1 replication in monocyte‐derived macrophages: enhanced HIV‐1 replication by N‐acetyl‐L‐cysteine (1994) (15)
A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers. (1998) (15)
Degradation of Escherichia coli chromosomal and plasmid DNA in serum. (1984) (15)
CAPD, a Permanent State of Peritonitis: A Study on Peroxidase Activity (1986) (15)
Comparison of Two Surveillance Methods for Detecting Nosocomial Infections in Surgical Patients (2002) (14)
Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement (1986) (14)
Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli. (1986) (14)
Detection of Salmonella species in fecal samples by immunomagnetic separation and PCR. (1995) (14)
Phagocytic and chemotactic function of polymorphonuclear and mononuclear leucocytes in patients with recurrent staphylococcal infections. (1980) (14)
Observations on constitutional resistance to infection. (1993) (14)
Prevention of infections in granulocytopenic patients by fluorinated quinolones. (1989) (14)
Down-regulation of human immunodeficiency virus type (HIV-1) production after stimulation of monocyte-derived macrophages infected with HIV-1. (1993) (14)
Carumonam Enhances Reactivity of Escherichia coli with Mono-and Polyclonal Antisera to Rough Mutant Escherichia coli J 5 (14)
Effect of iron on polymorphonuclear granulocyte phagocytic capacity: role of oxidation state and effect of ascorbic acid (1988) (14)
Class I integrons: prevalence and impact on antibiotic susceptibility in 278 consecutive unrelated Gram-negative blood isolates. (1999) (14)
Five-year surveillance of patients with communicable diseases nursed in isolation. (2001) (13)
Resistant Haemophilus influenzae in community-acquired respiratory tract infections: a role for cefixime. (2003) (13)
Digoxigenin labelled DNA probes for rapid detection of enterotoxigenic, enteropathogenic and Vero cytotoxin producing Escherichia coli in faecal samples (1992) (13)
Comparison of E Test and Double Disk Diffusion Test for Detection of Extended Spectrum Beta-Lactamases (2002) (13)
In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe. (2002) (13)
Host-pathogen relationships in respiratory tract infections. (1991) (13)
Influence of subinhibitory concentrations of clindamycin on opsonophagocytosis of Staphylococcus aureus, a protein-A-dependent process (1985) (13)
Structural Alterations in the Translational Attenuator of Constitutively Expressed erm(A) Genes inStaphylococcus aureus (2001) (13)
Nosocomial Pneumonia (2012) (13)
Empiric antimicrobial therapy (1991) (13)
Surface Proteins of Coagulase-Negative Staphylococci: Their Role in Adherence to Biomaterials and in Opsonization (1990) (13)
Natural occurring IgG and IgM antibodies to gram-negative bacteria and lipopolysaccharides in human sera (1988) (13)
Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group. (1999) (12)
Impact of hygienic measures on the development of methicillin resistance among staphylococci between 1991 and 1996 in a university hospital. (1998) (12)
Comparative study of ceftriaxone monotherapy versus a combination regimen of cefuroxime plus gentamicin for treatment of serious bacterial infections: the efficacy, safety and effect on fecal flora. (1988) (12)
Invasive and Noninvasive Group A Streptococcal Isolates with Different speA Alleles in The Netherlands: Genetic Relatedness and Production of Pyrogenic Exotoxins A and B (1999) (12)
The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences. (1989) (12)
Stopping short the spread of methicillin-resistant Staphylococcus aureus. (2001) (12)
Effect of influenza virus on phagocytic cells. (1982) (12)
Carriage of gram-negative bacilli in young Brazilian children with community-acquired pneumonia. (2001) (12)
Differences in the reporting rates of serious allergic adverse events from intravenous iron by country and population. (2012) (12)
Surveillance for Hospital-Acquired Infections on Surgical Wards in a Dutch University Hospital (2003) (12)
Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes. (1992) (12)
New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens (2006) (12)
Infections in the immunocompromised host : pathogenesis, prevention, and therapy : proceedings of the First International Symposium on Infections in the Immunocomprised Host held in Veldhoven, The Netherlands, 1-5 June, 1980 (1980) (12)
Staphylococcus aureus small colony variants: rate of selection and MIC values compared to wild-type strains, using ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin. (1999) (12)
Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus. (1979) (11)
Surface hydrophobicity and opsonic requirements of coagulase-negative staphylococci in suspension and adhering to a polymer substratum (1988) (11)
Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice. (1994) (11)
In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus. (2000) (11)
Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin. (1999) (11)
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria. (1991) (11)
Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis (1988) (11)
Inhibition by lipid A-specific monoclonal antibodies of priming of human polymorphonuclear leucocytes by endotoxin. (1991) (11)
Enhanced binding of murine monoclonal antibodies to lipopolysaccharide structures of Enterobacteriaceae after treatment with antibiotics (1989) (11)
Monoclonal antibodies that identify gram-negative bacteria using the magnetic immunoluminescence assay (1992) (10)
Prevention of bacterial and fungal infections in granulocytopenic patients. (1989) (10)
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections (1988) (10)
Value of Terminal Subculture of Automated Blood Cultures in Patients with Candidaemia (2000) (10)
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim (1993) (10)
Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: comparison of sulphonamide sensitive and resistant strains. (1987) (10)
Damage to chromosomal and plasmid DNA by toxic oxygen species. (1985) (10)
Opsonization of Staphylococcus aureus protects endothelial cells from damage by phagocytosing polymorphonuclear leukocytes (1987) (10)
The effect of culture conditions on the in-vitro adherence of methicillin-resistant Staphylococcus aureus. (1998) (10)
The influence of flucloxacillin and amoxicillin with clavulanic acid on the aerobic flora of the alimentary tract (1987) (10)
Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations. (2004) (10)
Interactions between Human Polymorphonuclear Leukocytes and Influenza Virus (1985) (10)
Antimicrobial resistance among isolates cultured from patients hospitalized with lower respiratory tract infection in Europe. (2002) (9)
In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae. (2001) (9)
Monoclonal antibodies specific for the phase-variant O-acetylated K1 capsule of Escherichia coli (1991) (9)
In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs. (2002) (9)
Iron and host defence (1983) (9)
Antibody mediated enhancement of HIV‐1 infection of an EBV transformed B cell line is CD4 dependent (1992) (9)
Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program. (1998) (9)
Cross-protection by anti-core glycolipid antibodies: evidence from animal experiments. (1997) (9)
Geographical distribution of quinolone resistance among Staphylococcus aureus, Escherichia coli and Klebsiella spp. isolates from 20 European university hospitals. SENTRY Participants Group. (1999) (9)
Cytotoxicity by human adherent cells: oxygen-dependent and -independent cytotoxic reactions by different cell populations. (1986) (9)
The phagocytic process and the role of complement in host defense. (1991) (9)
Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada. (2008) (9)
The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis. (2009) (9)
Pharmacodynamics of cefepime. (1990) (9)
A Pilot Study on Infection Control in 10 Randomly Selected European Hospitals: Results of a Questionnaire Survey (2000) (9)
Effects of ozone on cellular ATP levels in rat and mouse alveolar macrophages. (1991) (8)
Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes. (1991) (8)
Serum-induced lysis ofPseudomonas aeruginosa (1982) (8)
Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts. (1986) (8)
The effect of influenza virus on oxygen-dependent metabolism of human neutrophils. (1982) (8)
Disseminated Nocardia asteroides infection complicating renal transplantation. (1987) (8)
Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine (2015) (8)
S. pneumoniae isolados da nasofaringe de crianças sadias e com pneumonia: taxa de colonização e suscetibilidade aos antimicrobianos Nasopharyngeal isolates of S. pneumoniae from healthy carriers and children with pneumonia: colonization rates and antimicrobial susceptibility (2002) (8)
Methicillin resistant Staphylococcus aureus strains in the greater Düsseldorf area (1997) (8)
Host defence in CAPD treatment: the effect of the dialysate on cell function. (1990) (8)
Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides (1990) (8)
Antibody and complement-binding activity of viable and nonviable human spermatozoa. (1987) (8)
Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice (1996) (8)
N‐acetyl‐L‐cysteine‐induced up‐regulation of HIV‐1 gene expression in monocyte‐derived macrophages correlates with increased NF‐κB DNA binding activity (1997) (8)
Pharmacokinetics of ciprofloxacin after intraperitoneal administration in uninfected patients undergoing CCPD. (1992) (8)
Host-controlled modification and restriction of phages in coagulase-negative staphylococci. (1972) (8)
Testing phagocytic cell function (1985) (7)
Biology and clinical significance of peptidoglycan antibody response in staphylococcal infections. (1983) (7)
Infection of epithelial cell line HEp‐2 with human immunodeficiency virus type 1 is CD4 dependent (1993) (7)
Compatibility of Peritoneal Dialysis Fluids Containing Alternative Osmotic Agents with Cells Present in the Peritoneal Cavity (1994) (7)
A new procedure for the purification of streptococcal pyrogenic exotoxin A from Streptococcus pyogenes supernatant (1996) (7)
Amoxicillin-clavulanate prophylaxis against wound infections after clean-contaminated surgery. A controlled, randomized, prospective study. (1991) (7)
Surveillance of resistance against antimicrobial agents. (1999) (7)
Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx. (1989) (7)
Transient immunodepression. (1990) (7)
Influence of fluoroquinolones on expression and function of P fimbriae in uropathogenic Escherichia coli (1989) (7)
Granulocyte colony‐stimulating factor enhances protection by anti‐K1 capsular IgM antibody in murine Escherichia coli sepsis (1997) (7)
European Society of Clinical Microbiology (1984) (7)
Neutralization of Neisseria meningitidis outer membrane vesicles (2011) (7)
Phagocytic Defence against CAPD Peritonitis (1987) (7)
Intracellular pathways involved in TNF-alpha and superoxide anion release by Abeta(1-42)-stimulated primary human macrophages. (2001) (7)
In vitro stimulation of immune spleen cells enhances the number of anti-lipid A-producing hybridomas. (1989) (6)
Antibiotics enhance binding of lipid A-specific murine monoclonal antibody E5 to Gram-negative bacteria. (1994) (6)
Comparison of the autoSCAN-W/A and Vitek automicrobic systems for identification and susceptibility testing of bacteria (1992) (6)
Control of Nosocomial Multiresistant Enterobacteriaceae Using a Temporary Restrictive Antibiotic Agent Policy (2001) (6)
Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU. (2004) (6)
Detection of enterovirulent Escherichia coli associated with diarrhoea in Seville, southern Spain, with non-radioactive DNA probes. (1993) (6)
Evidence of cross-resistance between ciprofloxacin and non-fluoroquinolones in European Gram-negative clinical isolates. (2002) (6)
Nursing homes: not a source of methicillin-resistant Staphylococcus aureus in The Netherlands. (1994) (6)
Opsonization and phagocytosis of mucoid and non-mucoidPseudomonas aeruginosa strains (1982) (6)
Screening for methicillin-resistant Staphylococcus aureus (MRSA): one hour versus twenty-four hours sampling interval. (1999) (6)
RESTRICTION AND MODIFICATION OF PHAGES IN STAPHYLOCOCCAL PHAGE TYPING (1974) (6)
Surveillance of resistance against antimicrobial agents: a European perspective. (1999) (6)
Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity. (1987) (6)
Comment to Knoop et al. (1990) FEBS Letters 267, 9‐12, Toxin B of Clostridium difficile does not have enolase activity (1993) (6)
Real time assay of Aspergillus should be used in SARS patients receiving corticosteroids (2003) (6)
Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies. (1997) (6)
Proceedings: Netherlands Society for Microbiology meeting at Utrecht on 2 May 1973. The clearance of antibiotics by the artificial kidney. (1973) (6)
Characterisation and functional aspects of monoclonal antibodies specific for surface proteins of coagulase-negative staphylococci. (1991) (6)
Intraprostatic distribution of lomefloxacin following multiple-dose administration (1990) (6)
Long-term methicillin-resistant Staphylococcus aureus (MRSA) carriage and tagging of patient records: in Utrecht you're not MRSA-positive for life. (1997) (6)
Host — parasite relationship in staphylococcal infections: the role of the staphylococcal cell wall during the process of phagocytosis (2004) (6)
A flow cytometric rosetting assay for the analysis of Fc receptors and C3 receptors on HSV-infected cells. (1993) (6)
Frequency of enterovirulentEscherichia coli in diarrhoeal disease in The Netherlands (1993) (5)
Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models (1989) (5)
Single-dose prophylaxis with broad-spectrum penicillins (piperacillin and mezlocillin) in gynecologic oncological surgery, with observation on serum and tissue concentrations. (1990) (5)
[Methicillin-resistant Staphylococcus aureus in medical and paramedical personnel returned from work in a foreign hospital]. (2000) (5)
Invasive Group A Streptococcal Disease (1997) (5)
Reduction in cytokine release from human monocytes by modifications in cell wall structure of Staphylococcus aureus induced by subinhibitory concentrations of oxacillin. (1998) (5)
Detection of staphylococcal genes directly from cerebrospinal and peritoneal fluid samples using a multiplex polymerase chain reaction (1998) (5)
Deoxyribonucleic acid base composition of Staphylococcus epidermidis and its phages. (1971) (5)
Do quinolones really augment the antifungal effect of amphotericin B in vitro? (1985) (5)
C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients (2005) (5)
Tropical diseases : from molecule to bedside (2003) (5)
High-level gentamicin resistance in Enterococcus faecium and Enterococcus faecalis blood culture isolates from 23 European university hospitals. (2003) (5)
Colonization and transmission of meticillin-susceptible and meticillin-resistant Staphylococcus aureus in a murine nasal colonization model. (2011) (5)
The effect of staphylococcal peptidoglycan on polymorphonuclear leukocytes in vitro and in vivo. (1983) (5)
Atrio-ventricular shuntinfections and endocarditis due to Staphylococcus epidermidis. (1978) (5)
In Vitro Activity of AR-709 against Streptococcus pneumoniae (2008) (5)
Immunology of Staphylococci (1981) (5)
Recognition of Staphylococcus aureus by human phagocytes. Signals and disguises of the bacterial surface. (1983) (5)
Resistance: A sensitive issue. Strategic Council on Resistance in Europe (2005) (4)
Binding of HIV-1 to human follicular dendritic cells. (1993) (4)
Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections (1993) (4)
Discrimination by rabbit anti-idiotypic antibodies of two murine IgM monoclonal antibodies directed against lipid A. (1990) (4)
Influence of subinhibitory concentrations of Clindamycin on the phagocytosis of Staphylococcus aureus (1985) (4)
Occurrence and spread of SHV extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Curacao. (2003) (4)
Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains ofAcinetobacter anitratum in vitro (1985) (4)
Constitutional Resistance to Infection (1995) (4)
Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity (1993) (4)
Immune response in human pathology: infections caused by bacteria, viruses, fungi, and parasites (2005) (4)
diffusion tests for the detection of Extended Spectrum Beta-Lactamases (ESBLs) (2002) (4)
Is Methicillin-Resistant Staphylococcus Aureus More Contagious than Methicillin-Susceptible S. Aureus in a Surgical Intensive Care Unit? (2002) (4)
Amplification methods in diagnostic microbiology (1995) (4)
Effect of chlorhexidine and acetic acid on phagocytosis by polymorphonuclear leucocytes (1985) (4)
Functional microassay of complement activation by pneumococci (1992) (4)
Stimulated human neutrophils release intact BPI without a concomitant change in expression on the cell surface. (1995) (4)
Multivalent binding of toxin A from Clostridium difficile to carbohydrate receptors. (1994) (4)
Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages. (1990) (4)
Within-Host Selection of Drug Resistance in a Mouse Model Reveals Dose-Dependent Selection of Atovaquone Resistance Mutations (2017) (4)
Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infections (2005) (4)
The influence of cefepime on opsonophagocytosis of bacteria. (1989) (4)
Phagocytic defence against CAPD peritonitis. The bacterium, the phagocyte, and the doctor. (1987) (4)
Antimicrobial susceptibility of coagulase-negative staphylococci isolated between 1991 and 1996 from a German university hospital. (1999) (3)
Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections (1992) (3)
Prevention of infections in granulocytopenic patients by fluorinated quinolones. (1991) (3)
Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria (1986) (3)
APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro. (2003) (3)
Reactivity of monoclonal antibodies to Pseudomonas aeruginosa isolates from hospitalized adults and patients with cystic fibrosis. (1994) (3)
Comparative in vitro antimicrobial activity of carumonam (Ro 17-2301) and its influence on the activity of other antibiotics. (1987) (3)
Antibody-coated target cell membrane-induced chemiluminescence by human polymorphonuclear leukocytes. (1989) (3)
Immunogenicity of meningococcal LPS derived oligosaccharide-protein conjugates using isolated and synthetic oligosaccharides (1991) (3)
Influence of complement on sperm motility. (1990) (3)
Surveillance of antibiotic resistance. (1999) (3)
Bacteria, Phagocytes, and Bystander Cells (1988) (3)
Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains. (1988) (3)
Antimicrobial Functions of Neutrophils (1989) (3)
Host-parasite interaction in serious infections due to gram-negative bacteria (2006) (3)
Endocarditis caused by coagulase-negative staphylococci (2005) (3)
Tips and tricks from Staphylococcus aureus. (2003) (3)
Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus. (1998) (3)
Cefaclor in the treatment of skin, soft tissue, and urinary tract infections: a review. (1988) (3)
The role of HSV-induced Fc- and C3b (i)-receptors in bacterial adherence. (1994) (3)
Is Methicillin-Resistant Staphylococcus aureus More Contagious Than Methicillin-Susceptible S. aureus in a Surgical Intensive Care Unit? (2002) (3)
Worldwide resistance against antibiotics. (1994) (3)
Effect of iron on serotypes and haemagglutination patterns ofEscherichia coli in bottle-fed infants (1985) (2)
Analysis ofEscherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping (1991) (2)
The effect of influenza virus on human polymorphonuclear leukocytes (2004) (2)
[Diagnosis of uncomplicated urinary tract infections: complicated?]. (1988) (2)
Defects of phagocytic cells in patients with iron overload (1982) (2)
Prospects for monoclonal antibodies in the diagnosis and treatment of bacterial infections (1990) (2)
Induction of the early hypotensive phase by Escherichia coli: role of bacterial surface structures and inflammatory mediators. (1985) (2)
Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis? (1989) (2)
Complement and antibody enhance binding and uptake of HIV-1 by bone marrow cells. (1994) (2)
Influence of Subinhibitory Concentrations of Clindamycin on Phagocytosis of S.Aureus (1987) (2)
[Spread and control of a methicillin-resistant Staphylococcus aureus in an academic hospital]. (1990) (2)
TheKeyRoleofPeptidoglycan intheOpsonization of Staphylococcus Aureus (1977) (2)
[Epidemic of methicillin-resistant Staphylococcus aureus due to the transfer of 2 Dutch burn patients from a hospital outside of the Netherlands; who suffers the consequences?]. (2002) (2)
Estimating the public health cost of antimicrobial resistance in Europe: the example of MRSA [Report to the European Commission] (2004) (2)
Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice. (1993) (2)
Immune Response in Human Pathology: Infections Caused by Bacteria, Viruses, Fungi, and Parasites (2019) (2)
[Brain abscess: new insights in diagnosis and treatment]. (1982) (2)
Evaluation of protection by two endotoxin-neutralizing IgM monoclonal antibodies in different peritonitis models. (1997) (2)
Beta-lactam antibiotics enhance the binding of antibodies to outer membrane, non-LPS antigenic structures in Enterobacteriaceae (1989) (2)
Increased Expression of Leucocyte Adherence‐Related Glycoproteins by Polymorphonuclear Leucocytes during Phagocytosis of Staphylococci on an Endothelial Surface (1989) (2)
Phagocytosis of Bacteroides in suspension and on a glass surface determined by a modified fluorochrome assay (1989) (2)
Anti-human immunodeficiency virus type 1 activities of novel non-nucleoside reverse transcriptase inhibitors. (1994) (2)
Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5 (1996) (2)
[Urinary tract infection in the elderly; what does it mean?]. (1990) (2)
Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338) (1989) (2)
Prevention of infection by gram-negative microorganisms. (1991) (2)
A New Report of Triclabendazole Efficacy during Invading Phase Fasciolasis (1992) (2)
Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies. (1991) (2)
Inability of lipid A murine specific monoclonal antibody E5 to neutralize lipopolysaccharide biological activity in vitro (1994) (2)
ACTIVATION OF THE KININ GENERATING SYSTEM OF HUMAN PLASMA BY BACTERIAL FRAGMENTS (1982) (1)
Survival and Growth of Staphylococcus epidermidis within Phagocytes in Relation to Recurrent Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients (1990) (1)
In-vitro activities of quinupristin/dalfopristin and other anti-staphylococcal agents against methicillin-resistant strains of Staphylococcus aureus isolated over a 16-year period. (1998) (1)
Opsonic capacity of antisera raised against rough and smooth strains of Escherichia coli and Salmonella spp. (1985) (1)
THE ROLE OF SERUM AMYLOID A (SAA) IN SEPSIS AND LPS NEUTRALIZATION (1998) (1)
Electron Microscopic StudyofPhagocytosis ofEscherichia coliby HumanPolymorphonuclear Leukocytes (1985) (1)
Contact activation by bacterial fragments (1983) (1)
The antimicrobial agents annual. Vol. 1. (1986) (1)
Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40 (1992) (1)
A probe for the detection of methicillin-resistantStaphylococcus aureus (1990) (1)
Bacterial endotoxins decrease the number of respiratory β-adrenergic receptors in guinea pig lung (1983) (1)
[Detection of diarrhea-causing Escherichia coli using DNA-probes]. (1992) (1)
, Jan Verhoef , Alex Van Complex cepacia Burkholderia Identification of Isolates of the and VITEK 2 Automated Instruments for Comparative Evaluation of the BD Phoenix (2002) (1)
Glycopeptide Antibacterials and the Treatment of Biofilm-Related Infections (2005) (1)
The BCG controversy. (1994) (1)
In vivo TNF induction by culture supernatants of antibiotic-treated Escherichia coli 07:K1. Role of antibiotic class and concentration. (1996) (1)
The role of sialic acid in phagocytic cell function (1982) (1)
In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophages. (1997) (1)
The clearance of antibiotics by the artificial kidney (1973) (1)
Virulence of staphylococci in neonatal mice (2007) (1)
Infectious Diseases: Market of the Future? (2006) (1)
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens. (1987) (1)
Human polymorphonuclear leukocytes release leukotriene B4 during phagocytosis ofStaphylococcus aureus (1986) (1)
Detection of toxigenicClostridium difficile in fecal samples by colony blot hybridization (1993) (1)
Bacteriophage typing of coagulase-negative staphylococci (2005) (1)
Special issue. Eijkman Centennial on Infections in the 21st Century: Successes from the past, challenges for the future. (1999) (1)
Humoral immunity in human gram-negative septic shock. I: Potentially cross-protective anti-lipopolysaccharide antibodies (1989) (1)
Treatment Options for Streptococcus pneumoniae Strains Resistant to Macrolides, Tetracycline, Quinolones, or Trimethoprim/Sulfamethoxazole (2001) (1)
Production of leukotriene B4 by polymorphonuclear leukocytes during phagocytosis ofStaphylococcus aureus (2005) (1)
Antibiotic Modulation of Host Defense (1989) (1)
Humoral immunity in human Gram-negative septic shock II. Specific anti-bacterial immunity: opsonic activity and the effect of intravenous immunoglobulin G administration (1989) (1)
Mecanismos de defensa del huésped (1991) (1)
Quantitation of Conjugate Formation Between Human Polymorphonuclear Leukocytes and Antibody‐Coated Target Cells by Flow Cytometry: The Role of Fc Receptor and LFA‐1 Antigen (1989) (1)
Complement activating and opsonic capacity of monoclonal antibodies raised againstEscherichia coli O111 and its rough mutant J5 (1986) (1)
J Rollof factor alpha from human monocytes . induce differential release of tumor necrosis grown in the presence of different antibiotics Supernatants from Staphylococcus epidermidis (1996) (0)
Influence of antibiotics on phagocytic defense (1985) (0)
[The control of methicillin-resistant Staphylococcus aureus; worthwhile?]. (1990) (0)
The Opsonic Capacity of Monoclonal Antibodies Against Escherichia Coli 0111 and Its Rough Mutant E. Coli J5 (1988) (0)
supplement.infants with and without iron spp. in fecal samples from breast-fed and Bifidobacterium, Bacteroides, and Clostridium (2013) (0)
Can probiotics inhibit the growth of antibiotic resistant micro-organisms? In-vitro study (2006) (0)
Opsonic defences in newborn infants: decreased transfer of opsonic antibodies as a determinant of enhanced susceptibility to infection (1985) (0)
Acquired immune deficiency syndrome in the Netherlands (1984) (0)
[A new chapter in the history of tuberculosis]. (1993) (0)
HumanFibronectin Binding toStaphylococcal Surface Protein andItsRelative Inefficiency inPromoting Phagocytosis by HumanPolymorphonuclear Leukocytes, Monocytes, and Alveolar Macrophages (1981) (0)
hydroxylase expression in malignant and normal colon tissue from eight participants (2001) (0)
Nasopharyngeal S. pneumoniae isolates from healthy carriers and children with pneumonia: colonization rates and antimicrobial susceptibility (2002) (0)
Chapter 7. The prevention of infections in acute leukaemia: A com parison of Colistin plus neomycin with Colistin plus trime thoprim-sulfamethoxazole (1984) (0)
Aging and Antimicrobial Therapy (1976) (0)
Non-radioactive PCR method for quantification of HIV-infected peripheral blood mononuclear cells in HIV-positive subjects (1993) (0)
Influence ofFluoroquinolones on Expression andFunction of PFimbriae inUropathogenic Escherichia coli (1989) (0)
New treatment modalities for serious Gram-negative bacterial infections. (1993) (0)
(LPS)-Derived Oligosaccharide-Protein Conjugates EvokeOuterMembrane Protein- butNotLPS-Specific Bactericidal Antibodies in Mice:Influence ofAdjuvants (1993) (0)
Kinetics of IgG and completement dependent opsonization ofStaphylococcus aureus (1978) (0)
The effect of antisera on the induction of shock byE. coli (1983) (0)
P950 Quantifying the relationship between Staphylococcus aureus bacteraemia and Staphylococcus aureus bacteriuria (2007) (0)
Selective decontamination of the intestines: An important clinical treatment modality? (1991) (0)
Characterization and specification of monoclonal antibodies against Escherichia coli O111 and E. coli J5 (1985) (0)
Escherichia coli Increased Prevalence of Class I Integrons in (2014) (0)
Contents, Vol. 25, 1979 (1979) (0)
[Chemotherapeutic agents and antibiotics in urinary tract infections]. (1986) (0)
SPECIFIC AND NON-SPECIFIC OPSONISATION; ITS ROLE IN THE (NON-INFLAMMATORY) CLEARANCE OF TRANSLOCATED MICROORGANISMS* (2003) (0)
Effect of lipopolysaccharide, lipid A and polysaccharide on phagocytic cell function (1983) (0)
The use of a hybridization assay for the study of host defences against herpes simplex virus. (1989) (0)
Cytotoxicity by human adherent cells oxygen dependent and independent cytotoxicity by different cell populations (1985) (0)
Effects of Staphylococcal Peptidoglycan on Phagocytic Cells and Host Mediation Systems (1986) (0)
Selective decontamination of the digestive tract for the prevention of infection. (1993) (0)
Fighting antimicrobial resistant organisms (2006) (0)
Origin? -Lactamase: a Lipoprotein of Gram-Positive β Moraxella (Branhamella)catarrhalis BRO (2013) (0)
Prostatitis duetopenicillinase-pr oducing Neisseria gonorrhoeae Casereports (1982) (0)
Interactions between HIV-infected monocyte-derived endothelial cells result in increased expression of CC chemokines (2000) (0)
Clindamycin enhances complement-and antibody-dependent phagocytosis of Staphylococcus aureus by human polymorphonuclear granulocytes (1985) (0)
Determination of the Relationship between Group A Streptococcal Genome Content, M Type, and Toxic Shock Syndrome by a Mixed Genome Microarray (cid:1) † (2007) (0)
[The interaction between food, nutritional status, metabolism and orally administered antimicrobial agents]. (1985) (0)
Effects oflysosomotropic amines on humanpolymorphonuclear leucocyte function (1984) (0)
Diverging pathways for LPS and CD14 in human monocytes (1997) (0)
Grip in laparoscopic surgery by means of adhesion: A background information report (2005) (0)
COLZ ANTIBODIES IN OPSONISATION AND PROTECTION AGAINST INFECTION (2008) (0)
Pulmonary Surfactant Enhances the Surface Phagocytosis of Staphylococcus aureus by Rat Alveolar Macrophages (1990) (0)
Opsonic Requirements forPhagocytosis ofStreptococcus pneumoniae typesVI,XVIII, XXIII, andXXV (1977) (0)
Proceedings: Netherlands Society for Microbiology meeting of the medical section at Bilthoven on 10 October 1974. Virulence of staphylococci in neonatal mice. (1975) (0)
Inhibition of Oxidative Effects of Human Polymorphonuclear Granulocytes by Rosmarinic Acid (1986) (0)
Gram-negative Rod Bacteraemia: function of phagocytic cells and opsonic activity of serum (1979) (0)
TumorNecrosis Factor Alpha(TNF-a) Production inMice Immunized withEscherichia coli: Correlation withMortality after Lethal Challenge andProduction ofa Native Inhibitor ofTNF-(xActivity (1993) (0)
Contents, Supplement 1, 1988 (1988) (0)
Amyloid-β stimulation of primary human macrophages results in CC-chemokine production (2000) (0)
Membrane binding of iron ii and poly and mononuclear iron iii complexes by neutrophils (1986) (0)
Netherlands Society for Microbiology, Medical Section and Netherlands Association of Laboratory Physicians, joint meeting. Rotterdam, 10 November 1983. Abstracts. (1982) (0)
Sensitivity to serum and phagocytosis by polymorphonuclear leucocytes ofE. coli (1978) (0)
[Monotherapy or combination therapy in severe bacterial infections?]. (1989) (0)
[New macrolides, azalides and streptogramins; current role and their future perspective]. (1992) (0)
Metabolic activation of human polymorphonuclear leukocytes by opsonized Haemophilus influenzae type b. (1988) (0)
Toon van Pathway Complement Activation Lipopolysaccharide-Mediated Classical Gram-Negative Bacteria Prevents Serum Amyloid P Component Bound to (2000) (0)
Human nonspecific effector leukocytes: possible function in herpes simplex virus infection. (1986) (0)
The opsonisation and phagocytosis of group B by polymorphonuclear leucocytes. A comparison of sulphonamide sensitive and resistant strains (1988) (0)
J Verhoef 16 S rRNA gene . conformation polymorphism analysis of the fluorescence-based PCR-single-strand Molecular identification of bacteria (1995) (0)
[Microorganisms in the air and the sick-building syndrome]. (1993) (0)
The role of the phagocyte in resistance to infection (1982) (0)
Nicholas R. Di Luzio, PhD (1926–1986) (1986) (0)
Detection ofAntibodies againstLipopolysaccharides ofEscherichia coli andSalmonella R andSStrains byImmunoblotting (1985) (0)
Tropical Diseases (2003) (0)
The pharmacokinetics of the new penicillins: amoxycillin and flucloxacillin, in patients with terminal renal failure undergoing haemodialysis (1973) (0)
Epitope Specificity ofRabbit Immunoglobulin G (IgG) Elicited by Pneumococcal Type23FSynthetic Oligosaccharide- andNative Polysaccharide-Protein (1994) (0)
Restriction and modification of phages in coagulase-negative staphylococci (2005) (0)
Antimicrobial treatment : Lessons from the past, promises for the future (2000) (0)
, Jan Verhoef and Dana with Defined Resistance Determinants Gram-Positive European Clinical Isolates In Vitro Activity of Daptomycin against (2004) (0)
Bacteria, phagocytes, and bystander cells. Interaction between Staphylococcus aureus, polymorphonuclear leukocytes, and endothelial cells. (1988) (0)
Trends in β-lactam resistance among enterobacteriaceae. Discussion (1998) (0)
FP1.08 Failure to control a multidrug-resistant Enterobacter cloacae outbreak despite adequate implementation of recommended infection control measures (2006) (0)
A8 Immune response in human pathology: Infections caused by bacteria, viruses, fungi, and parasites (2011) (0)
Comparison ofTyping MethodsforClostridium difficile Isolates (1993) (0)
Evidence-based medicine in infectious diseases and microbiology: Still a long way to go (2003) (0)
Subsequent Binding Is Through CD 11 b / CD 18 Activate Human Neutrophils Via CD 14 While Lipopolysaccharide-Coated Erythrocytes (1999) (0)
Enterovirulent Escherichia coli can cause bacteraemia in immunocompromised patients. (1993) (0)
pathogenesis, and vaccines. Streptococcus pneumoniae: virulence factors, (2013) (0)
Discrimination ofEpidemic andNonepidemic Methicillin- Resistant Staphylococcus aureus Strains ontheBasis ofProtein A GenePolymorphism (1994) (0)
Influence ofTemperature on Opsonization andPhagocytosis ofStaphylococci (1977) (0)
Host defence in surgical patients; neutrophil and monocyte function, serum opsonic activity and interaction with antimicrobial agents (1986) (0)
Neuropathogenesis of HIV-1 Infection Dementia Complex : Implications for the Increased Peroxynitrite Activity in AIDS (1999) (0)
SHOCK INDUCING PROPERTIES OF E. COLI IN RELATION TO SURFACE STRUCTURES AND EFFECT OF ANTISERA (1983) (0)
Two rapid complementary methods to detect progressive zidovudine resistance mutations in mononuclear cells of HIV-infected patients. (1996) (0)
INFECT . IMMUN . * immune serum O heated Immune serum * pooled serum O heated pooled serum (0)
Antimicrobial agents and opsonic defence. (1987) (0)
Proceedings: Netherlands Society for Microbiology meeting at Utrecht on 2 May 1973. The pharmacokinetics of the new penicillins: amoxycillin and flucloxacillin, in patients with terminal renal failure undergoing haemodialysis. (1973) (0)
Prostatitis due to penicillinase-producing Neisseria gonorrhoeae: Case reports (1982) (0)
Antimicrobial Therapy in Patients on Haemodialysis (1976) (0)
Funct iona l defects in phagocyt ic cells (2004) (0)
Gram-Negative Bacterial Infections in the Critically Ill: Pathophysiological and Clinical Aspects (1984) (0)
Application of mucoadhesive in a colon inspection device (2007) (0)
The effect of culture conditions on the in-vitro adherence of met hicillin-resistan t Staphylococcus aureus (0)
Population Staphylococcus aureus Gene Is Widely Disseminated in mecA (2002) (0)
IN STAPHYLOCOCCAL DISEASE (1981) (0)
Genes and spectrum : The theoretical limits. Discussion (1998) (0)
Effect of influenza virus on phagocytic cell function (1985) (0)
P1594 Evaluation of MLVA and spa-typing as a rapid method for studying relationships of human and bovine Staphylococcus aureus (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jan-jaap Verhoef?

Jan-jaap Verhoef is affiliated with the following schools:

Jan-jaap Verhoef's Academic­Influence.com Rankings

Jan-jaap Verhoef's Degrees

Why Is Jan-jaap Verhoef Influential?

Jan-jaap Verhoef's Published Works

Published Works

What Schools Are Affiliated With Jan-jaap Verhoef?

Jan-jaap Verhoef's AcademicInfluence.com Rankings